You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NSRX Buy Disclosure
Teleman Dan Benjamin · SEC Form 4 · Filed Jun 22, 2026
Buy
Calculated transaction value
$20.3K
Teleman Dan Benjamin Chief Executive Officer
NSRX
Nasus Pharma Ltd
NSRX
Transaction date
Jun 17, 2026
Public filing date
Jun 22, 2026
Filing lag
Filed 5 days later
NSRX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 6,550 shares @ $3.1
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001493152-26-029484
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$20.3K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nasus Pharma Ltd NSRX Current | Buy | Jun 17, 2026 | $20.3K |